The contradictory effects of MPA and P4 in CRC treatment could be due to the chemical differences, which could produce different actions at the cellular level, binding potencies to PR in colon cancers, treatment conditions, and/or different types of colon cancer cell lines. This evidence concerns the gene PGR and colorectal carcinoma.